Clinical trial NCT03485430: Tapering From Long-term Opioid Therapy in Chronic Pain Population. Randomized Controlled Trial With 12 Months Follow up
Official title: Tapering of Prescribed Opioids in Patients With Long-term Non-malignant Pain - Efficacy and Effects on Pain, Pain Cognitions, and Quality of Life (TOPIO): a Study Protocol for a Randomized Controlled Clinical Trial With a 12 Month Follow-up
Study type: INTERVENTIONAL
Overall status: ACTIVE_NOT_RECRUITING
Phase: NA
Conditions: Chronic Pain
Analgesics, Opioid
Opioid Withdrawal
Opioid Use
Substance Use Disorders
Lead sponsor: Lund University Hospital
Sponsor class: OTHER
Collaborators: name: Lund University
name: University Hospital, Linkoeping
name: Sahlgrenska University Hospital
First posted: 2018-04-02
Enrollment: 140
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SUPPORTIVE_CARE

Brief summary: This randomized controlled study compares tapering of long-term opioid therapy in a population with chronic non-cancer pain with control group constituted of waiting list. Half of participants receives intervention at baseline and the other half are controls but receives intervention after 4 months. Ethical approval to follow up excluded participants denying tapering at baseline.

Detailed description: Chronic non-cancer pain is a major problem in society and a common cause to seek health care. The suffering is complex as it, besides pain, often includes psychological symptoms and may decrease the ability to participate in work life. Pharmacological treatments have limited possibilities to ease suffering. Opioids used in this population have evidence to ease pain and to some extent increase physical ability when used in limited treatment periods and in selected patients. Medium to long-term opioid therapy, extended beyond three months, lack evidence of easing pain or increase physical ability.

The current study is conducted on three specialized pain care units (Skane University Hospital; Lund, Sahlgrenska University Hospital Gothenburg and University Hospital, Linkoeping) and aims at taper long-term opioid therapy with support from physician and nurse and study the effects of tapering.

Method: Randomized controlled study, without concealment. Waiting-list constitutes the control-group. Intervention means tapering with a motivated patient. Follow up at four and twelve months.

Primary end-point: collected opioid prescriptions registered in The National Board of Health and Welfare registry expressed in milligram of morphine equivalent.

Secondary end-point: Data will be retrieved from the Swedish Quality Registry for Pain Rehabilitation. The database contains participants' self-report of variables measuring the impact of rehabilitation on depressive symptoms, anxiety, rating of pain and acceptance to pain. Assessments are made prior to, at the end of and one year after discharge of the rehabilitation program.

As denying tapering or participation is shown to be as common as decision to taper drugs at baseline an extended ethical approval was acquired also retrospective. This approval covers obtaining collected prescribed medication and prescribed opioid replacement therapy (Buprenorphine or Methadone) after one year. The study may describe the excluded population better this way.

Eligibility criteria: Inclusion Criteria:

A long-term opioid therapy with daily intake due to chronic pain condition, by prescription. Willing to enter an intervention aiming at taper opioid therapy.

Exclusion Criteria:

No daily intake of opioids. Shorter duration of opioid therapy than 3 months. Repeated intake of non-prescribed opioids or other illegal drugs. Refusal to perform drug-screening Perceived medical risks of waiting with tapering of opioids (e.g: raising opioid doses after acute pancreatitis caused by excessive alcohol intake or kidney disease stage 4-5 in combination with excessive alcohol intake and high doses of opioids).

Primary outcomes:
measure: Opioid consumption
timeFrame: 12 months
measure: Opioid consumption
timeFrame: 4 months
Secondary outcomes:
measure: Numeric Pain Rating Scale (NPRS)
timeFrame: 12 months
Other outcomes:
measure: Hospital Anxiety and Depression scale (HADS)
timeFrame: 12 months
measure: Tampa Scale for Kinesiophobia (TSK)
timeFrame: 12 months
measure: Pain Catastrophizing Scale (PCS)
timeFrame: 12 months
measure: Chronic Pain Acceptance Questionnaire (CPAQ-8)
timeFrame: 12 months
measure: Perceptions of health
timeFrame: 12 months
Locations:
city: Lund
country: Sweden
facility: Lund University Hospital
state: Skåne
city: Gothenburg
country: Sweden
facility: Paincentre Sahlgrenska University Hospital
state: Västra Götaland
city: Linköping
country: Sweden
facility: Pain and rehabilitation centre Linköping University Hospital
state: Östergötland
Study officials:
affiliation: Lund University
name: Åsa IRingqvist, MD, PhD
role: STUDY_CHAIR
References:
citation: Henrik G, Patrik M, Anders H, Ulf J, Marcelo RF, Asa R. Tapering of prescribed opioids in patients with long-term non-malignant pain (TOPIO)-efficacy and effects on pain, pain cognitions, and quality of life: a study protocol for a randomized controlled clinical trial with a 12-month follow-up. Trials. 2021 Jul 28;22(1):503. doi: 10.1186/s13063-021-05449-5.